Ln Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 14.15 Cr
as on 17-11-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -116.49%
(FY 2023)
- Ebitda -76.29%
(FY 2023)
- Net Worth -29.05%
(FY 2023)
- Total Assets 213.29%
(FY 2023)
About Ln Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 14.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vakkalanka Raman, Gunneswara Prasad, Shamanvi Vakkalanka, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290TG2020PTC139194
- Company No.
139194
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2020
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ln Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chonika Vakkalanka  | Director | 01-Feb-2021 | Current |
| Vakkalanka Raman | Director | 06-Mar-2021 | Current |
| Gunneswara Prasad | Director | 13-Feb-2020 | Current |
| Shamanvi Vakkalanka | Director | 13-Feb-2020 | Current |
Financial Performance of Ln Pharmaceuticals.
Ln Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 116.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 29.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ln Pharmaceuticals?
In 2023, Ln Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asman Software Solutions Private LimitedActive 13 years 4 monthsVakkalanka Raman is a mutual person
Ram Navami Green Film Technologies Private LimitedActive 1 year 5 monthsVakkalanka Raman, Gunneswara Prasad and 2 more are mutual person
- Rn Green Film Technologies Private LimitedActive 1 year 4 months
Vakkalanka Raman, Gunneswara Prasad and 2 more are mutual person
- Ln Laboratories Private LimitedActive 4 years 10 months
Vakkalanka Raman, Gunneswara Prasad and 2 more are mutual person
- R9 Projects And Developers Private LimitedActive 1 year 8 months
Vakkalanka Raman is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ln Pharmaceuticals?
Unlock and access historical data on people associated with Ln Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ln Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ln Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
